EUVIMEDEUVIMED entdecken
Crossref

Diagnostic Performance of 68 Ga-PSMA-11 PET/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer

Alexander Light, Stefan Lazic, Kate Houghton, Max Bayne, Martin J Connor, Henry Tam, Hashim U Ahmed, Taimur T Shah, Tara D Barwick

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.123.266527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Alexander Light und 8 weiteren Autor:innen. Beteiligte Einrichtung: Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, United Kingdom. Hauptthemen laut MEDLINE: Multiparametric Magnetic Resonance Imaging, Prostatic Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For men with prostate cancer who develop biochemical failure after radiotherapy, European guidelines recommend reimaging with 68Ga-PSMA-11 PET/CT and multiparametric MRI (mpMRI). However, the accuracy of 68Ga-PSMA-11 PET/CT for detecting intraprostatic recurrences is unclear, both with and without mpMRI.

Methods

A single-center retrospective study of a series of patients investigated for radiorecurrence between 2016 and 2022 is described. All patients underwent 68Ga-PSMA-11 PET/CT, mpMRI, and prostate biopsy. PET/CT images were interpreted independently by 2 expert readers masked to other imaging and clinical data. The primary outcome was the diagnostic accuracy of PET/CT versus mpMRI and of PET/CT with mpMRI together versus mpMRI alone. The secondary outcome was the proportion of cancers missed by mpMRI but detected by PET/CT. Diagnostic accuracy analysis was performed at the prostate hemigland level using cluster bootstrapping.

Results

Thirty-five men (70 hemiglands) were included. Cancer was confirmed by biopsy in 43 of 70 hemiglands (61%). PET/CT sensitivity and negative predictive values (NPVs) were 0.89 (95% CI, 0.78-0.98) and 0.79 (95% CI, 0.62-0.95), respectively, which were not significantly different from results by MRI (sensitivity of 0.72; 95% CI, 0.61-0.83; P = 0.1) (NPV of 0.59; 95% CI, 0.41-0.75; P = 0.07). Specificity and positive predictive values were not significantly different. When PET/CT and MRI were used together, the sensitivity was 0.98 (95% CI, 0.92-1.00) and NPV was 0.93 (95% CI, 0.75-1.00), both significantly higher than MRI alone (P = 0.003 and P < 0.001, respectively). Specificity and positive predictive values remained not significantly different. MRI missed 12 of 43 cancers (28%; 95% CI, 17%-43%), of which 11 of 12 (92%; 95% CI, 62%-100%) were detected by PET/CT.

Conclusion

For detecting intraprostatic radiorecurrence, 68Ga-PSMA-11 PET/CT has high sensitivity that is not significantly different from mpMRI. When 68Ga-PSMA-11 PET/CT and mpMRI were used together, the results conferred a significantly greater sensitivity and NPV than with mpMRI alone. 68Ga-PSMA-11 PET/CT may therefore be a useful tool in the diagnosis of localized radiorecurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiparametric Magnetic Resonance ImagingProstatic NeoplasmsMaleHumansGallium RadioisotopesPositron Emission Tomography Computed TomographyRetrospective Studies

Stichwörter der Autor:innen

PSMA PET/CTmultiparametric MRIprostate cancerradiotherapyrecurrence

Substanzen

PSMA-11Gallium Radioisotopes

Autor:innen und Institutionen

  • Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Department of Imaging, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; and.
  • Department of Imaging, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; and tara.barwick@nhs.net.
  • Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Zitieren

APA

Light, A., Lazic, S., Houghton, K., Bayne, M., Connor, M. J., Tam, H., Ahmed, H. U., Shah, T. T., & Barwick, T. D. (2024). Diagnostic Performance of 68 Ga-PSMA-11 PET/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.266527

Vancouver

Light A, Lazic S, Houghton K, Bayne M, Connor MJ, Tam H, et al. Diagnostic Performance of 68 Ga-PSMA-11 PET/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.123.266527

BibTeX
@article{Light2024,
  author = {Light, Alexander and Lazic, Stefan and Houghton, Kate and Bayne, Max and Connor, Martin J and Tam, Henry and Ahmed, Hashim U and Shah, Taimur T and Barwick, Tara D},
  title = {Diagnostic Performance of 68 Ga-PSMA-11 PET/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.123.266527}
}
Kostenlos starten →